The new monthly online training series "NUM Insights: Projects and Results from the Network of University Medicine" will start in October 2025 and is aimed primarily at doctors and scientists. New results and current developments from the NUM sub-projects will be presented in a compact 45-60 minutes. The training courses take place at the beginning of each month via MS Teams and are certified with 1 CME point from the responsible LÄK. NUM Insights is organised by the NUM Local Coordination Units (LCUs).
The Reseach Infrastructure AKTIN kicked off the event on 7 October with 40 participants from the fields of medicine, IT, science management and public health. Dr Wiebke Schirrmeister, Head of the AKTIN Office and Coordinator of the Emergency Admissions Register and associated third-party funded projects, presented the NUM Platform for Acute Intensive Care and Emergency Medicine (AKTIN). Using concrete examples, she explained the use and access process for a data request to the register and presented a brief snapshot of the results of these research requests. In the subsequent discussion, questions about the participation of other Emergency Departments and the development of new data were answered. The event was rated very positively in the final short evaluation.
The next lecture will take place on
Monday, 10 November 2025, 17:00-17:45:
Prof. Dr. Matthias May (University Hospital Erlangen) & Prof. Dr. Sylvia Mechsner (Charité - Universitätsmedizin Berlin) Early detection of Adenomyosis - "FADEN"
Participation via MS Teams-Link
Further NUM Insights dates:
Thursday, 04.12.2025
Alexander Dilthey (Heinrich Heine University Düsseldorf): GenSurv, MolTraX and genomics-based infection chain tracing
Thursday, 08.01.2025
Prof. Dr Florian Klein (Academic Medical Center Cologne): COVIM - Development of an immunity platform
To the event
Monday, 09.02.2026
Prof. Dr Maria Vehreschild (University Medicine Frankfurt): First results and experiences from RAPID-REVIVE
Monday, 09.03.2026
Prof. Dr Patrick Meybohm (Academic Medical Center Würzburg): Challenges for patients acutely unable to give informed consent in clinical trials